S3E8: Drug Related Morbidity and Mortality in Maine: An Economic Perspective

In this episode, we cover an article by Angela Daley, Prianka Sarker, Liam Siguad, Marcella Sorg, and Jamie Wren titled, “Drug-related Morbidity and Mortality in Maine: Lost Productivity from 2015-2020.” Daley is an assistant professor of economics at the University of Maine, Sarker and Wren are both research associates at the Margaret Chase Smith Policy Center, Sorg a forensic anthropologist, and Siguad a research assistant at the Mercatus Center in Arlington, VA who was a graduate student when this study was conducted. After briefly summarizing the article, we will speak with Dr. Sorg and Prianka Sarker about the opioid epidemic and how we go about quantifying some of the costs of the opioid epidemic.

This article was published in volume 31, issue 1, of Maine Policy Review, a peer-reviewed academic journal published by the Margaret Chase Smith Policy Center. For all citations for data provided in this episode, please refer to Daley et al.’s article , which can be found here: https://digitalcommons.library.umaine.edu/cgi/viewcontent.cgi?article=1887&context=mpr

 

Transcript

[00:00:00] Eric Miller: Of the significant challenges today, few are as insidious as the opioid crisis, which has divided public discourse and devastated communities across the country. In this episode, we'll recap an article published in 2022, assessing the economic harm of lost labor productivity in Maine.

This is the Maine Policy Matters Podcast from the Margaret Chase Smith Policy Center at the University of Maine. I'm Eric Miller, research associate at the center. On each episode of Maine Policy Matters, we discuss public policy issues relevant to the state of Maine. Today we'll be covering an article by Angela Daley, Priyanka Sarker, Liam Siguad, Marcella Sorg and Jamie Wren titled, "Drug Related Morbidity and Mortality in Maine: Lost Productivity from 2015 to 2020". Daley is an assistant professor of economics at the University of Maine. Sarker and Wren are both research associates at the Margaret Chase Smith Policy Center, Sorg is a forensic anthropologist, and Siguad is a research assistant at the Mercatus Center in Arlington, Virginia, who was a graduate student at the time the study was conducted. After briefly summarizing the article, we will speak with Dr. Sorg and Priyanka Sarker about the opioid epidemic and how we go about quantifying some of the costs of the opioid epidemic.

This article is published in Volume 31, issue 1 of Maine Policy Review, a peer reviewed academic journal published by the Margaret Chase Smith Policy Center. For all citations for data provided in this episode, please refer to Daley et al.'s article, which can be found in the episode description.

The increase of prevalence of overdose deaths has been a devastating phenomenon since the pharmaceutical opioids, namely Oxycontin, kicked off an epidemic that has evolved and worsened since the late 1990's. In addition to the heartbreaking losses, there have been significant economic impacts as well, with Maine ranking among the highest in the nation for per capita overdose death rate as of recent years.

The emotional toll on individuals, families, and communities is far reaching, leading to poor physical and mental health, reduced quality of life, lost productivity, increased accidents and crime, and higher social welfare and healthcare costs. The economic impact is staggering, estimated at just over 1 trillion in 2017 for the United States and 6.8 billion in 2017 for Maine alone. In this paper, Daley et al. use a human capital approach to estimate loss productivity from drug related morbidity and mortality in Maine. This approach measures the lost value to society that occurs when individuals cannot fully contribute to market and non-market activities. For example, individuals may be less likely to participate in the labor market, or they